Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Danta

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Neurology|January 1, 1977
An investigation into reading epilepsyG Danta, P J Dowling, S R Hammond
Clinical and Experimental Neurology|January 1, 1985
Ophthalmological complications of cryptococcal meningitisJ D Blackie, G Danta, T Sorrell, et al.
The Medical Journal of Australia|April 16, 1990
Neurocysticercosis: an under-recognized cause of neurological problemsD Crimmins, P J Collignon, D Dwyer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1973
Interactions of L-dopa and amantadine in patients with ParkinsonismB Cox, G Danta, H Schnieden, et al.
Nature|September 24, 1971
Nature of the nerve lesion caused by a pneumatic tourniquetJ Ochoa, G Danta, T J Fowler, et al.
Journal of Neuroimmunology|January 1, 1988
Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogenD O Willenborg, N A Bowern, G Danta, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 1, 2008
Utility of a patient survey in identifying fluctuations in early stage Parkinson's diseaseP A Silburn, G D Mellick, B I Vieira, et al.
Seizure|December 1, 1996
A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizuresR G Beran, S F Berkovic, N Buchanan, et al.
Epilepsia|December 22, 1998
Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsyR G Beran, S F Berkovic, F M Dunagan, et al.
American Journal of Human Genetics|September 16, 1999
A novel syndrome of episodic muscle weakness maps to xp22.3M M Ryan, P Taylor, J A Donald, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Neurology|January 1, 1977
An investigation into reading epilepsyG Danta, P J Dowling, S R Hammond
Clinical and Experimental Neurology|January 1, 1985
Ophthalmological complications of cryptococcal meningitisJ D Blackie, G Danta, T Sorrell, et al.
The Medical Journal of Australia|April 16, 1990
Neurocysticercosis: an under-recognized cause of neurological problemsD Crimmins, P J Collignon, D Dwyer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1973
Interactions of L-dopa and amantadine in patients with ParkinsonismB Cox, G Danta, H Schnieden, et al.
Nature|September 24, 1971
Nature of the nerve lesion caused by a pneumatic tourniquetJ Ochoa, G Danta, T J Fowler, et al.
Journal of Neuroimmunology|January 1, 1988
Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogenD O Willenborg, N A Bowern, G Danta, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 1, 2008
Utility of a patient survey in identifying fluctuations in early stage Parkinson's diseaseP A Silburn, G D Mellick, B I Vieira, et al.
Seizure|December 1, 1996
A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizuresR G Beran, S F Berkovic, N Buchanan, et al.
Epilepsia|December 22, 1998
Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsyR G Beran, S F Berkovic, F M Dunagan, et al.
American Journal of Human Genetics|September 16, 1999
A novel syndrome of episodic muscle weakness maps to xp22.3M M Ryan, P Taylor, J A Donald, et al.
Pageof 5